Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day

References

• SommerATielschJMKatzJRelationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore eye surveyArch Ophthalmol1991109109010951867550
   PubMed Web of Science ®Google Scholar
• RoulandJFBerdeauxGLafumaAThe economic burden of glaucoma and ocular hypertension: implications for patient managementDrugs Aging20052231532115839720
   PubMed Web of Science ®Google Scholar
• LeeAGBeaverHAVisual loss in the elderly – Part I: Chronic visual loss: what to recognize and when to referClinical Geriatrics2003114653
   Google Scholar
• KingmanSGlaucoma is second leading cause of blindness globallyBull World Health Org20048288788815640929
   PubMed Web of Science ®Google Scholar
• LeskeMCHeijlDKHusseinMFactors for glaucoma progression and the effect of treatment: the early manifest glaucoma trialArch Ophthalmol2003121485612523884
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol200212070171312049574
   PubMed Web of Science ®Google Scholar
• HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
   PubMed Web of Science ®Google Scholar
• LeskeMCHeijlAHymanLBengtssonBKomaroffEFactors for progression and glaucoma treatment: the Early Manifest Glaucoma TrialCurr Opin Ophthalmol20041510210615021220
   PubMedGoogle Scholar
• European Glaucoma SocietyTerminology and Guidelines for Glaucoma3rd edSavona, ItalyEditrice Dogma, S.r.l2004
   Google Scholar
• RemoSJWang-PuiSComparison of latanoprost with fixed combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight week, randomized, open-label, parallel-group, multicenter study in Latin AmericaClin Ther20042675575615220019
   PubMed Web of Science ®Google Scholar
• GugletaKOrgulSFlammerJExperience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists’ officesCurr Med Res Opin20031933033512841926
   PubMed Web of Science ®Google Scholar
• CrichtonACHarasymowyczPHutnikCMEffectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line studyJ Ocul Pharmacol Ther20102650351120874498
   PubMed Web of Science ®Google Scholar
• ClineschmidtCMWilliamsRDSnyderEAdamsonsIAA randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study GroupOphthalmology1998105195219599787369
   PubMed Web of Science ®Google Scholar
• BoyleJEGhoshKGieserDKAdamsonsIAA randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamideOphthalmology1998105194519519787368
   PubMed Web of Science ®Google Scholar
• TorisCBZhanGLYablonskiMECamrasCBEffects on aqueous flow of dorzolamide combined with either timolol or acetazolamideJ Glaucoma20041321021515118464
   PubMed Web of Science ®Google Scholar
• StrohmaierKSnyderEDuBinerHAdamsonsIThe efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study GroupOphthalmology1998105193619449787367
   PubMed Web of Science ®Google Scholar
• FrancisBADuLTBerkeSEhrenhausMMincklerDSCosopt Study GroupComparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol – a randomized controlled trial and a replacement studyJ Clin Pharm Ther20042937538015271105
   PubMed Web of Science ®Google Scholar
• HutzelmannJOwensSSheddenAAdamsonsIVargasEComparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study GroupBr J Ophthalmol199882124912539924327
   PubMed Web of Science ®Google Scholar
• HendererJDWilsonRPMosterMRTimolol/dorzolamide combination therapy as initial treatment for intraocular pressure over 30 mmHgJ Glaucoma20051426727015990605
   PubMed Web of Science ®Google Scholar
• RenieriGFührerKScheitheKLorenzKPfeifferNThiemeHEfficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patientsJ Ocul Pharmacol Ther20102659760320977366
   PubMed Web of Science ®Google Scholar
• SheddenAAdamsonsIAGetsonAJComparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT ™) in patients with elevated intraocular pressure in a randomized clinical trialGraefes Arch Clin Exp Ophthalmol20102481757176420437244
   PubMed Web of Science ®Google Scholar
• HutnikCNeimaDIbrahimFTolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2010458159020668720
   PubMedGoogle Scholar
• JothiRIsmailAMSenthamaraiRPalSA comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patientsIndian J Pharmacol20104236236521189906
   PubMed Web of Science ®Google Scholar
• FramptonJEPerryCMTopical dorzolamide 2%/timolol 0.5% ophthalmic solution: a review of its use in the treatment of glaucoma and ocular hypertensionDrugs Aging20062397799517154662
   PubMed Web of Science ®Google Scholar
• SallKNGreffLJJohnson-PrattLRDorzolamide/timolol combination versus concomitant administration of brimonidine and timololOphthalmology200311061562412623832
   PubMed Web of Science ®Google Scholar